NetworkNewsBreaks

WednesdayFeb 14, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Holds Webinar to Discuss Positive Phase 3 Fibromyalgia Data, NDA Filing Plans

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, recently held a key opinion leader (“KOL”) webinar hosted by Alliance Global Partners (“AGP”). The webinar featured two thought leaders in the field of fibromyalgia, Dr. Daniel Clauw and Dr. Lesley Arnold. The thought leaders discussed the positive data from a Phase 3 study of Tonmya(TM) (also known as TNX-102 SL, cyclobenzaprine HCI sublingual tablets) for the management of fibromyalgia and the path to file an NDA for FDA approval in H2 2024. According to the announcement, clinical results show that Tonmya(TM) has…

Continue Reading

TuesdayFeb 13, 2024 3:49 pm

NetworkNewsBreaks – IBN’s CNW to Elevate Visibility for ZJ Events in 2024

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 60+ brands within IBN (“InvestorBrandNetwork”), has announced its renewed partnership as the official newswire for ZJ Events in 2024. ZJ Events, an innovative organizer hosting multiple trade shows across the USA and South America every year, is set to deliver a captivating 2024 event series, featuring the BizCann Expo and Alternative Products Expo, the nation’s largest CBD and hemp event (formerly known as USA CBD Expo). Leveraging its extensive array of corporate-communications solutions, IBN aims to elevate the visibility of exhibitors, participants and the conferences among…

Continue Reading

TuesdayFeb 13, 2024 3:46 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Financial Report, Company Update on ‘Strongest Quarter to Date’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting financial results for the three months ended Dec. 31, 2023; the company is also reporting a business update. Highlights of the report included the company regaining compliance with the NASDAQ minimum-bid price requirement in January; the achievement of several key milestones, including CARB and federal EPA and NHTSA certification for its Class 1 and Class 3 vehicles, as well as IRS approval as a “qualified manufacturer”; the completion of its lightweight service truck body for the All-Electric Mullen THREE; the submission of a preapplication to the U.S. Department…

Continue Reading

TuesdayFeb 13, 2024 3:28 pm

NetworkNewsBreaks – DealFlow’s Upcoming Conference to Showcase Innovative Products and Services in the Alternative Financing Space

DealFlow Events, host and organizer of hundreds of investment themed conferences over the past two decades, today announced the 2nd Annual Venture Debt Conference 2024. As the world’s largest forum dedicated to non-dilutive financing strategies for emerging growth companies, the event is slated to take place on March 6, 2024, at the historic Edison Ballroom in New York City. The full-day forum will focus on the growing role of venture debt and the varied forms of financing that minimize ownership dilution, offering unique networking opportunities and in-depth strategy discussions for VC-backed and emerging growth companies. Attendees will glean insights into…

Continue Reading

TuesdayFeb 13, 2024 3:25 pm

NetworkNewsBreaks – Nextech3D.ai (CSE: NTAR) (OTCQX: NEXCF) (FSE: 1SS) Lands $1.8M Deal, Demonstrating Scalability of Its Technology

Nextech3D.AI (CSE: NTAR) (OTCQX: NEXCF) (FSE: 1SS), a generative AI-powered 3D model supplier for major e-commerce retailers, today announced a significant $1.8 million 3D modeling contract with a major enterprise client. The deal provides significant revenue to be delivered in 2024 for the company and showcases Nextech3D.ai’s position as an industry leader for 3D modeling in the $6.3 trillion e-commerce market*. “Nextech3D.ai has been at the forefront of the massive shift from 2D static images to 3D immersive experiences, utilizing augmented reality and cutting-edge generative AI technology to create photo-realistic 4K 3D models that cater to the specific needs of…

Continue Reading

TuesdayFeb 13, 2024 2:39 pm

NetworkNewsBreaks — Vision Marine Technologies Inc. (NASDAQ: VMAR) Names MarineMax Executive to Board

Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry, announced that Anthony E. Cassella Jr., executive vice president finance and chief accounting officer at MarineMax Inc. (NYSE: HZO) has been appointed to its board of directors; Cassella will serve as an independent director. According to the announcement, the appointment reflects VMAR’s leading role in marine technology innovation and underscores its commitment to strong corporate governance; the company noted that the veteran’s background and industry knowledge “will bring incredible value to the next chapter of Vision Marine's mission to become the leading provider…

Continue Reading

TuesdayFeb 13, 2024 2:23 pm

NetworkNewsBreaks – Optec International Inc. (OTC: OPTI) Focus of Judgment, RB Capital Provides Shareholder Update

Optec International (OTC: OPTI) is the focus of a judgment filed by California-based RB Capital Partners Inc., a private investment fund. A recent announcement noted that RB Capital was clarifying the judgment and releasing a shareholder update. According to the announcement, RB Capital observed that it was the largest investor and legitimate shareholder of OPTEC and was “forced to bring a shareholder derivative action against the company to secure our judgment, oust the failing [CEO] Roger Pawson and to try to preserve the assets of the company.” RB Capital filed the lawsuit, noting that Pawson used the company for self-dealing…

Continue Reading

TuesdayFeb 13, 2024 2:20 pm

NetworkNewsBreaks – Renovaro Inc. (NASDAQ: RENB) Fusing AI and Biotech to Accelerate Personalized Medicine, GEDiCube, Cyclomics Enter LOI to ‘Change the Field’

Renovaro (NASDAQ: RENB) today announced the completion of its acquisition of GEDi Cube Intl Ltd. (“GEDiCube”). Renovaro, which means renew, combines the power of the AI Health Tech platform of GEDiCube with the advanced cell and gene-therapy Biotech platform of Renovaro Biosciences to accelerate precision, personalized medicine, marking a new era in healthcare innovation. According to the announcement, the two subsidiaries will be under the parent organization, which was renamed Renovaro Inc. “We believe this combination marks a significant milestone in the journey of personalized medicine,” said Renovaro’s CEO Mark Dybul, MD. “Together, we believe that we are poised to…

Continue Reading

TuesdayFeb 13, 2024 2:12 pm

NetworkNewsBreaks – GEMXX Corp. (GEMZ) Announces Groundbreaking Start for January Product Deliveries

GEMXX (OTC: GEMZ), a pioneering mine-to-market gold, gemstone and jewelry producer, today announced a stellar start to the year with impressive product deliveries worth $1,051,374 at retail for the month of January. According to the announcement, January’s deliveries mark an incredible 600% increase compared to the same period last year, highlighting GEMXX's strong growth trajectory and its effective business strategies. “Our January delivery results are a testament to the hard work and dedication of the GEMXX team,” said Jay Maull, CEO of GEMXX Corporation. “Our ability to achieve such significant deliveries is a clear indication of our competitive edge in…

Continue Reading

TuesdayFeb 13, 2024 2:02 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Appoints Liat Halpert as Head of Business Development, Sales

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the appointment of Liat Halpert as head of business development and sales. Halpert brings extensive pharmaceutical sales and marketing experience and joins Scinai following 14 years at Novartis, most recently having served as marketing and commercial excellence lead for cell and gene therapies for Central, Southern and Eastern Europe. “I am pleased to welcome Liat to Scinai,” said Amir Reichman, Scinai’s CEO. “Her pharmaceutical sales, marketing and leadership experience, in particular in…

Continue Reading